Reuters logo
BRIEF-Cerveau Technologies announces research collaboration agreement with Janssen Pharmaceuticals
October 16, 2017 / 7:02 PM / in 2 months

BRIEF-Cerveau Technologies announces research collaboration agreement with Janssen Pharmaceuticals

Oct 16 (Reuters) - Cerveau Technologies Inc:

* Says announced a research collaboration agreement with Janssen Pharmaceuticals Inc for use of MK-6240​ ‍​

* Says collaboration is focused on using MK-6240 as a biomarker in Janssen neurodegenerative disease research studies​

* Says parties will collaborate on using MK-6240 to diagnose and evaluate new treatments for neurodegenerative diseases in humans​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below